DaVita (NYSE:DVA) Hits New 12-Month High – Still a Buy?

DaVita Inc. (NYSE:DVA) shares reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $215.33 and last traded at $209.6180, with a volume of 754564 shares traded. The stock had previously closed at $207.91.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on DVA. Weiss Ratings reissued a “hold (c+)” rating on shares of DaVita in a research report on Monday, June 8th. TD Cowen upped their price objective on DaVita from $144.00 to $201.00 and gave the stock a “hold” rating in a research note on Monday, May 11th. UBS Group increased their price objective on DaVita from $190.00 to $235.00 and gave the company a “buy” rating in a report on Thursday, May 7th. Zacks Research raised shares of DaVita from a “hold” rating to a “strong-buy” rating in a research note on Thursday, May 7th. Finally, Truist Financial boosted their target price on shares of DaVita from $158.00 to $205.00 and gave the stock a “hold” rating in a report on Friday, May 8th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, DaVita presently has a consensus rating of “Hold” and a consensus price target of $199.17.

DaVita Stock Up 1.1%

The firm has a market cap of $13.69 billion, a P/E ratio of 19.79, a PEG ratio of 0.69 and a beta of 0.91. The business has a fifty day moving average of $185.86 and a 200 day moving average of $151.37.

DaVita (NYSE:DVA) last released its quarterly earnings data on Tuesday, May 5th. The company reported $2.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.33 by $0.54. DaVita had a negative return on equity of 270.37% and a net margin of 5.65%.The firm had revenue of $3.42 billion for the quarter, compared to analyst estimates of $3.36 billion. During the same quarter in the prior year, the company earned $2.00 earnings per share. The business’s revenue for the quarter was up 6.0% compared to the same quarter last year. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. Research analysts expect that DaVita Inc. will post 15.07 EPS for the current year.

Insider Buying and Selling

In other DaVita news, CFO Joel Ackerman sold 51,471 shares of DaVita stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $192.10, for a total transaction of $9,887,579.10. Following the completion of the transaction, the chief financial officer directly owned 132,434 shares of the company’s stock, valued at $25,440,571.40. The trade was a 27.99% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Kathleen Alyce Waters sold 15,405 shares of the company’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $208.40, for a total transaction of $3,210,402.00. Following the completion of the transaction, the insider owned 109,194 shares in the company, valued at approximately $22,756,029.60. This represents a 12.36% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.50% of the stock is currently owned by insiders.

Institutional Trading of DaVita

Hedge funds and other institutional investors have recently modified their holdings of the stock. Root Financial Partners LLC grew its stake in DaVita by 128.0% in the 1st quarter. Root Financial Partners LLC now owns 187 shares of the company’s stock valued at $29,000 after buying an additional 105 shares during the last quarter. Elevation Wealth Partners LLC grew its holdings in shares of DaVita by 147.3% during the 4th quarter. Elevation Wealth Partners LLC now owns 277 shares of the company’s stock worth $31,000 after purchasing an additional 165 shares in the last quarter. Caitlin John LLC acquired a new stake in DaVita during the fourth quarter worth about $34,000. Sankala Group LLC acquired a new stake in shares of DaVita during the 4th quarter worth approximately $39,000. Finally, Canada Pension Plan Investment Board bought a new position in DaVita in the second quarter valued at about $43,000. Institutional investors own 90.12% of the company’s stock.

About DaVita

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.